Biohaven Ltd. (BHVN) NYSE
9.20
+0.12(+1.32%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
9.20
+0.12(+1.32%)
Currency In USD
| Market Cap | 1.22B |
| Enterprise Value | 1.26B |
| P/E Ratio | -2.1 |
| PEG Ratio | -0.04 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 10.49 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -1.5 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.39 |
| Return On Equity | -8.66 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -4.14M |
| EBITDA | -727.46M |
| Net Income | -738.82M |
| Diluted EPS | -6.86 |
| Total Cash | 347.82M |
| Total Cash/Share | 2.36 |
| Total Debt | 280.27M |
| Total Debt/Equity | 2.16 |
| Current Ratio | 7.41 |
| Book Value Per Share | 0.88 |
| 52-Week Change | -52.84 |
| 52-Week High | 20.09 |
| 52-Week Low | 7.48 |
| Moving Average 50 Days | 9.66 |
| Moving Average 200 Days | 12.12 |
| Average Volume | 2.12M |
| Shares Outstanding | 105.87M |
| % Held by Institutions | 114.76 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |